Home Newsfeeds Cowen & Co. Downgrades Graphite Bio to Market Perform

Cowen & Co. Downgrades Graphite Bio to Market Perform

Cowen & Co. analyst Phil Nadeau downgrades Graphite Bio (NASDAQ:GRPH) from Outperform to Market Perform.

byBenzinga Newsdesk

February 23, 2023

1 minute read

Cowen & Co. analyst Phil Nadeau downgrades Graphite Bio (NASDAQ:GRPH) from Outperform to Market Perform.

61% Of Americans Think AI Could Spell The End Of Humanity, Echoing Elon Musk’s Warning: Report

By Ananya Gairola

May 18, 1:13 AM

Are we on the brink of an AI apocalypse? According to a recent survey, most U.S. citizens share Elon…

GOOG

Here’s How Much $100 Invested In Take-Two Interactive 15 Years Ago Would Be Worth Today

By Benzinga Insights

November 8, 12:10 PM

Take-Two Interactive (NASDAQ:TTWO) has outperformed the market over the past 15 years by 6.39% on an annualized basis producing an average annual return of 12.95%. Currently, Take-Two Interactive has a market capitalization of $15.83 billion.

TTWO

Daxor Corporation Closes Q4 2023 With Growth In New Sales To Hospital Systems And Increased Utilization Of Its BVA-100 Blood Volume Diagnostic Across The U.S. At Existing Accounts

By Benzinga Newsdesk

February 7, 9:06 AM

Daxor's ezBVA Lab Service Plays a Significant Role in Driving Growth and Fostering Widespread Adoption Oak Ridge, TN, Feb. 07, 2024 (GLOBE NEWSWIRE) -- Daxor Corporation (NASDAQ:DXR), the global leader in blood

DXR

$100 Invested In This Stock 10 Years Ago Would Be Worth $800 Today

By Benzinga Insights

July 13, 3:38 PM

Alphabet (NASDAQ:GOOGL) has outperformed the market over the past 10 years by 11.82% on an annualized basis producing an average annual return of 22.63%. Currently, Alphabet has a market capitalization of $1.48 trillion.

GOOGL

Cowen & Co. Downgrades Graphite Bio to Market Perform

Related Posts

61% Of Americans Think AI Could Spell The End Of Humanity, Echoing Elon Musk’s Warning: Report

Here’s How Much $100 Invested In Take-Two Interactive 15 Years Ago Would Be Worth Today

Daxor Corporation Closes Q4 2023 With Growth In New Sales To Hospital Systems And Increased Utilization Of Its BVA-100 Blood Volume Diagnostic Across The U.S. At Existing Accounts

$100 Invested In This Stock 10 Years Ago Would Be Worth $800 Today